CONMED Corp — Director's Dealing 2016

Nov 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-11-03

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-03	Common Stock	M	2000	$19.26	Acquired	20120	Direct
2016-11-03	Common Stock	F	1360	$39.18	Disposed	18760	Direct
2016-11-03	Common Stock	M	4000	$27.63	Acquired	22760	Direct
2016-11-03	Common Stock	F	3257	$39.18	Disposed	19503	Direct
2016-11-03	Common Stock	M	4000	$26.09	Acquired	23503	Direct
2016-11-03	Common Stock	F	3158	$39.18	Disposed	20345	Direct
2016-11-07	Common Stock	S	2555	$40.40	Disposed	17790	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-03	Sars (Stock Appreciation Rights)	$19.26	M	2000	Disposed	2020-06-01	Common Stock (2000)	Direct
2016-11-03	Sars (Stock Appreciation Rights)	$27.63	M	4000	Disposed	2021-06-01	Common Stock (4000)	Direct
2016-11-03	Sars (Stock Appreciation Rights)	$26.09	M	4000	Disposed	2022-06-01	Common Stock (4000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $40.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.